Safety and efficacy of 3-month dual antiplatelet therapy after drug-eluting stents: a network bayesan meta-analysis of randomised clinical trials

25 August 2018 (00:00 - 00:00)

Organised by:

Sign in to view the resources

About the speaker

Doctor Giuseppe Ferrante

Humanitas University, Milan (Italy)

11 More presentations in this session

Presentation thumbnail

Women in medicine: addressing the gender gap in interventional cardiology in Australia and New Zealand

Doctor S. Burgess (Sydney, AU)

Abstract Slides

Presentation thumbnail

Predictors for angiographic edge restenosis of 2nd generation drug-eluting stents: Integrated angiographic analyses from the post-marketing surveillance studies of everolimus-eluting stents in Japan

Professor K. Kozuma (Tokyo, JP)

Abstract Slides

Presentation thumbnail

Do women benefit from bilateral internal mammary artery bypass grafting?

Miss F. Saraiva (Porto, PT)

Presentation thumbnail

Utilizing telemedicine platforms to construct population-based AMI management - Results from half a million patient encounters in Latin America Telemedicine Infarct Network (LATIN)

Doctor S. Mehta (Miami, US)

Abstract Slides

Presentation thumbnail

Duration of dual anti platelet therapy in elective drug coated balloon angioplasty

Doctor N. Corballis (Norwich, GB)

Abstract Slides

Access the full session

Session thumbnail

Poster Session 5 - Interventional cardiology - General aspects

The Event

ESC Congress 2018

25 August - 29 August 2018

You may be interested in

Congress Presentation

Percutaneous intervention is better than surgery in real life for most patients: pro

Congress Presentation

State-of-the-art lecture on adjunctive antiplatelet therapy for patients undergoing percutaneous coronary intervention

Congress Presentation

Association of PCI with outcomes in stable coronary artery disease

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources